The Cancer

Don't Miss

Childhood Most cancers Survivors Face Lengthy-Time period Meningioma Danger

Researchers at UT Southwestern Medical Heart led a research revealed in JAMA Community Open which discovered that particular chemotherapies are related to an elevated long-term...

Professional Discusses FDA Approval of Chemo-Free Possibility for EGFR-Mutated Lung Most cancers

The FDA has accepted Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the primary and solely subcutaneous, chemo-free therapy for sufferers with EGFR-mutated non-small cell lung most...

FDA Clears Protocol Replace for Tasquinimod in Myelofibrosis Trial

Lively Biotech has obtained optimistic suggestions from regulators on a protocol modification to its ongoing proof-of-concept scientific trial evaluating tasquinimod in sufferers with myelofibrosis, a...

Vital Information

Facts

Latest Articles

How Does Colorectal Most cancers Screening Forestall and Detect Most cancers?

Dr. Usman Shah, who's a medical oncologist at Overlook Medical Heart, section 1 and gastrointestinal oncology medical director, emphasised in an interview with...

GLP-1 Remedy Linked to Improved Outcomes in Polycythemia Vera

GLP-1a therapy in sufferers with polycythemia vera was linked to vital reductions in mortality, illness development, and severe issues.Remedy with glucagon-like peptide-1 receptor...

How Fall and My Daughter’s Most cancers Go Collectively for Me

Debbie Legault is the mom of a younger lady who was identified with breast most cancers at 27. Compensate for Debbie’s blogs right here!My...

PredicineCARE Urine Take a look at Advances in FDA Overview for Bladder Most cancers

PredicineCARE, a urine-based take a look at, is beneath FDA assessment as a companion diagnostic for bladder most cancers, constructing on earlier information...

Dealing with Leukemia Once more, Suleika Jaouad Lives Each Day like It’s Her First

Suleika Jaouad, an writer and affected person advocate, is going through most cancers for the third time in 15 years; nevertheless, she is...

Hot Topics